Category

Buy Sell Hold

Buy, Sell or Hold

Buy, Sell or Hold: Is it Time for Investors to TAP into Molson Coors?

By , Money Morning - • Print | Email

Almost everyone has overindulged in a beer or three. And while that occasionally turns out to be something of a big mistake, the thirst for beer is hard to quench.

That's one of the reasons why I'm bullish about Molson Coors Brewing Company (NYSE: TAP).

Formed by the merger of Molson of Canada and Coors of the United States in 2005, this marriage joined two companies that have seen it all in the beer business–even to the point where their product was illegal during the days of prohibition.

Even still, both companies managed to not only survive but thrive.

Today, the descendants of the original founders still greatly influence Molson Coors and have a vested interest in the company's profitability and the incentive to keep the family legacies alive and well for future generations.

But that's only a small piece of why I like this company. The better reason is its ability to grow sales.

Buy, Sell or Hold

Buy, Sell or Hold: Is Boston Scientific Poised for a Turnaround?

By , Money Morning - • Print | Email

Investors in Boston Scientific (NYSE: BSX) have been through the wringer in recent years.

The medical device maker hit its peak back in 2004, reaching highs near $44. Since then the company is down over 82% and has been hovering under $10 for years.

So how did shares of Boston Scientific fall so hard?

Much of the blame can be traced back to the company's ill-conceived 2006 plan to become the leading player in the medical device industry by outbidding Johnson & Johnson (NYSE: JNJ) for Guidant Corp to the tune of $27.3 billion.

It's a deal Fortunemagazine described at the time as the second-worst takeover deal ever.

But the problems didn't stop there. Boston Scientific ran into all types of issues with the quality of not only Guidant products, but its own as well.

This led to a string of product recalls, patient lawsuits, run-ins with the FDA and a share price that could never seem to find a bottom.

But now, with its new CEO, Michael Mahoney — who has a cautious but optimistic view for Boston Scientific — there just may be enough new catalysts to turn the company around.

Here's the deal…

Buy, Sell or Hold

Buy, Sell or Hold: What's So "Special" About Kellogg?

By , Money Morning - • Print | Email

Everybody knows Kellogg Company (NYSE: K) by its superb line of breakfast cereals.

What they don't know is that thanks to the purchase of Pringles from Procter & Gamble (NYSE: PG) , Kellogg has become second in the snacks business behind PepsiCo (NYSE: PEP).

In fact, since Kellogg completed the $2.7 billion Pringle acquisition on June 1, 2012 the company's share price has increased over 30% with nary a pause.

Now I realize that eating just one Pringles potato chip is impossible, but does that justify the market's appetite for Kellogg's shares?

Here's my breakdown on the stock…

Investing in Smart Grid Technology: Two Stocks to Power Up Your Portfolio

By , Money Morning - • Print | Email

There's a saying that goes, when you lose the Internet it's like 1979 but when you lose power it's like 1879.

For a while, we actually lived through it when a big swath of the mid-Atlantic lost power in July. Let me tell you, it was ugly.

I've lived in Northern Virginia for most of my life. I remember dill pickles in a barrel at the grocery store, Quisp and Quake cereal, and Frank Howard was my hero on the Washington Senators, if that gives you an idea of old I am. In all of those years I have never seen anything like it.

The power went out on Friday night and by mid-morning Saturday, there wasn't a hotel room with air conditioning to be found in a 50 mile radius.

So many street lights were out that it was up to the drivers to figure who went next, and you're talking a metropolitan area of about 12 million people cycling through. That doesn't even account for the fact that I-95 cuts through the whole area with trucks, tourists, etc.

It was completely nuts.

Now imagine what it was like in India where nearly 700 million lost power. Yes, that's 700 million suddenly without power.

That's like the entire U.S. going down and then adding another 200+ million on top of that.

The lesson in both instances though is the same: It's necessary to build a "smart" grid.

To continue reading please, please click here...

FLIR Systems (Nasdaq: FLIR): Grow Your Portfolio With The "Eye in the Sky"

By , Money Morning - • Print | Email

Smile…. you're on the 21st century's version of Candid Camera.

Whether you're an Islamic troublemaker in North Waziristan, a rowdy football fan, or a hopeful immigrant trying to slip across the border, the eye in the sky sees everything.

In the halls of power, there's a term for this. It's called the surveillance society. And it is one of the biggest trends inside and outside the military industrial complex.

Also known as ISR – intelligence, surveillance and reconnaissance-it's an outgrowth of more than a decade of war in Iraq and Afghanistan. It's a place where everyone has heard of unmanned aerial vehicles or UAVs.

But while UAVs are an amazing technology in themselves, they aren't very effective unless they can report on what they see -that's the ISR piece of the puzzle.

And that's precisely where a company like FLIR Systems Inc. (Nasdaq: FLIR) comes in. FLIR provides the optics and equipment to make it all happen both in the air and on the ground.

What Analysts are Missing About FLIR Systems

Founded in 1978, FLIR has developed a reputation for building world-class equipment.

And now that these systems have proven themselves in some of the harshest conditions on Earth, the company is expanding to a broad number of other applications in market sectors outside the military.

However, looking at FLIR's chart, it's an understatement to say that this specialty defense imaging stock has been hit hard by the budget cuts and the winding down of our presence in Iraq and Afghanistan.

To continue reading, please click here...

Innovation Investing: Now is the Time to Buy ABB Ltd. (NYSE:ABB)

By , Money Morning - • Print | Email

As investors, we constantly hear that the markets are forward looking. There is a good reason for that.

The future is precisely where smart investors need to be focused these days.

It doesn't matter whether you are investing for income or for growth, it is what's over the horizon that matters most.

One of those horizons is the "New Energy Age".

It's a place where technology is having an enormous impact on how we generate, distribute and consume energy on every level.

And the companies that embrace this paradigm shift are creating a whole new approach to the markets I call Innovation Investing.

One of the poster children for Innovation Investing is ABB (NYSE: ABB). A go-to player in every major market, including the United States, ABB is a must for any long-term investor.

The Story Behind ABB (NYSE: ABB)

The Switzerland-based company is a global leader in power and automation technologies that enable utility and industry customers to improve their performance while lowering environmental impact.

For some that may sound "green" but for most of its customers, it's about improving efficiencies and the bottom line.

This is a company that is not only a major global player in all the major markets in the world– developed and developing–but it does almost everything in the energy business. And usually it is on a scale that few others can match.

Plus, ABB kicks off a nice dividend yield that's approaching 4%.

To continue reading, please click here...

Buy, Sell or Hold: Oracle Corp. (NASDAQ: ORCL) is The Last Cash Cow

By , Money Morning - • Print | Email

Today marks my 117th and final article at Money Morning.

Viewed as a portfolio, I'm proud that those 117 calls are up on average. Before we get into my take on Oracle Corp (NASDAQ: ORCL) I'd like to take a look back over years.

The 2010 picks have held up nicely with 12 positive and just six negative, for a 10 percent positive return on average, as of this writing.

The hot long ideas of 2011 turned out to be El Paso (NYSE: EP) and Sturm, Ruger & Co. (NYSE: RGR). El Paso is up 48% while Ruger is up 78%.

So far in 2012 the column's best sell idea, Petrobras (NYSE ADR: PBR), has dropped 15% since January 24. Our Jan. 30 "Buy" recommendation on Apple (NASDAQ: AAPL) is up 32%.

It's been a great run and my thanks again to the entire Money Morning staff for the opportunity.

Now, let's talk about the one company that Buy, Sell or Hold has not covered yet but I believe is deserving of the column's final recommendation: Oracle Corp (NASDAQ: ORCL).

To continue reading, please click here...

Buy, Sell or Hold: Why Now is the Time to Buy Bacterin International
Holdings Inc. (AMEX: BONE)

By , Money Morning - • Print | Email

Getting old isn't all it's cracked up to be.

When I was young, dumb, and all too daring, I took chances that in hindsight were pretty boneheaded, and I'm still paying for them.

Once I even jumped off the roof of my grandmother's house, thinking I was going to catch the storm drain as I dropped by. Why I believed that I'm not sure.

Instead, I ended up in the hospital needing five reconstructive surgeries that included bone grafts donated from my own hip.

In fact, today I still suffer from a dull ache in the same hip, which is a decent trade off because I can still use my arm.

Fortunately, medicine has come a long way since the day I stood on that roof eyeing up that gutter.

Today someone in the same situation would turn to a biotech company to provide the material needed for that surgery, not a human donor.

This is one of the reasons I like Bacterin International Holdings Inc. (AMEX: BONE)

Breaking Down Bacterin

Bacterin designs, manufactures and markets revolutionary dermal and skeletal health products, bone graft material, biological scaffolds and related medical devices.

They also design and produce bioactive, anti-microbial coatings for implantable devices that act as barriers to infection.

Their total potential markets in the United States alone are estimated at over $8.5 billion. Of that, Bacterin has gained a small but growing percentage.

But here's what more impressive:

To continue reading, please click here...

Buy, Sell or Hold: Hecla Mining Co.'s (NYSE:HL) Silver Moment

By , Money Morning - • Print | Email

Shares of Hecla Mining Co. (NYSE:HL) have been beaten up during what should be extremely bullish conditions for the largest silver miner in the United States.

I think that presents some value for investors willing to take a contrarian view.

As I write this, Hecla Mining is down 50% in the past 52 weeks. I honestly find this situation a headscratcher − especially in light of where silver prices may be headed.

What's more, the company is sitting on a horde of cash and carries no net debt. This means the company is stable and able to function without access to capital markets.

As an investor, I consider this situation nearly bulletproof.

Notice that I said "nearly" – not completely.

There is one thing that can severely damage a company with a solid balance sheet. It is called lawsuits.

Unfortunately for Hecla, they had a bad 2011 in that regard.

The company had two fatal accidents at a producing mine with an additional third event that injured seven more workers.

These events caused the Mine Safety and Health Administration ( MSHA) to close the shaft in question and require the removal of built-up material before Hecla can resume operations.

Known as the Lucky Friday mine, it may be shut down throughout 2012.

In the aftermath, a specific group of investors became so angry with management's disclosures relating to these fatal accidents that they filed suit.

This bad luck streak in the mines and in the courtrooms has hammered the stock price to a point I now find cheap, even considering the potentially damaging lawsuits.

In short, when I look at Hecla Mining today, I see value investing is at its best.

I love to find an out-of-favor stock where the fundamentals are still strong and the company is already profitable.

To continue reading, please click here...

Buy, Sell or Hold: The Real Winner in the Yahoo (YHOO) vs Facebook Fight Could Be Augme Technologies (AUGT)

By , Money Morning - • Print | Email

I love to find asymmetric risk/reward scenarios in the market.

You can do that with a small company which has the ability to unlock a large payday – and I believe I have found one with Augme Technologies Inc. (OTC: AUGT ).

To understand the value of mobile marketing company Augme, first we have to look at what Yahoo! Inc. (Nasdaq: YHOO) has done to Facebook.

Ripples shot through the technology space last week when Yahoo launched an all-out patent assault against Facebook.

Yahoo is demanding billions in licensing fees for the use of its technologies.

Yahoo has asserted claims on patents that include the technical mechanisms in Facebook's ads, privacy controls, newsfeed and messaging service.

In simple terms, Yahoo is getting ready to try and bring Facebook to its knees through legal means.

"Yahoo has a responsibility to its shareholders, employees and other stakeholders to protect its intellectual property," a Yahoo spokesman said in an e-mailed statement. "We must insist that Facebook either enter into a licensing agreement or we will be compelled to move forward unilaterally to protect our rights."

Should Yahoo sue Facebook, it would mark the first major legal battle among technology giants in the social media sphere.

It would indicate a major escalation of patent litigation that has already swept up the smartphone and tablet sectors and high-tech stalwarts such as Apple, Microsoft and Motorola.

Yahoo's patent claims come hot on the heels of Facebook's IPO announcement to raise money that would roughly give them a $100 billion valuation.

This lawsuit threat can only have Facebook's management, its bankers and lawyers rushing to secure some sort of defensive arsenal to fight off this and other pending attacks.

While this battle has captured everyone's attention, what I find more interesting is Yahoo's seemingly blatant hypocrisy.

Yahoo appears to be throwing rocks from its glass house at the neighbors by wanting to make others pay for the unauthorized use of its patented technology.

What Yahoo is seemingly trying to ignore is that it, too, has been accused of the same type of intellectual property theft – and the accuser is Augme Technologies.

To continue reading, please click here...